Sapphire Therapeutics' Series A Round

Sapphire Therapeutics raised a round of funding on April 01, 2001.

Sapphire is a biopharmaceutical company developing and commercializing promising compounds that are ready for clinical or pre-clinical testing in oncologic and metabolic disease. A drug candidate in …

Articles about Sapphire Therapeutics' Series A Round: